Literature DB >> 198494

Detection of soluble antigen of Epstein-Barr virus by the enzyme-linked immunosorbent assay.

W C Wallen, J M Mattson, P H Levine.   

Abstract

The enzym-linked immunosorbent assay (ELISA) was compared with the microcomplement-fixation test for sensitivity and reliability in detection of antibody to soluble antigen of Epstein-Barr virus. ELISA was found to be more sensitive (up to 160 times more antibody) in detecting levels of antibody than the complement-fixation assay. The ELISA test was shown also to be comparably reliable to the complement-fixation assay in detecting immunity to this antigen; only one false-positive response was found in tests of 21 sera. Because this assay is completely quantifiable, it provides an easy, rapid, and highly sensitive technique for the detection of antibody to antigen of Epstein-Barr virus.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 198494     DOI： 10.1093/infdis/136.supplement_2.s324

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  4 in total

1.  Antibody assays for varicella-zoster virus: comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination, and complement fixation.

Authors:  B Forghani; N J Schmidt; J Dennis
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

2.  Enzyme-linked immunosorbent assay for detection of antibodies to influenza A and B and parainfluenza type 1 in sera of patients.

Authors:  F R Bishai; R Galli
Journal:  J Clin Microbiol       Date:  1978-12       Impact factor: 5.948

3.  Use of monoclonal antibodies in an enzyme immunoassay for rapid identification of group B Streptococcus types II and III.

Authors:  R A Polin; R Kennett
Journal:  J Clin Microbiol       Date:  1980-04       Impact factor: 5.948

Review 4.  Enzyme immunoassays with special reference to ELISA techniques.

Authors:  A Voller; A Bartlett; D E Bidwell
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.